Cargando…
Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19)
Both pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD) are risk factors for coronavirus disease 2019 (COVID-19). Patients with lung injury and altered pulmonary vascular anatomy or function are more susceptible to infections. The purpose of the study is to ascert...
Autores principales: | Tian, Zhe, Cen, Lilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266291/ https://www.ncbi.nlm.nih.gov/pubmed/37216361 http://dx.doi.org/10.33073/pjm-2023-015 |
Ejemplares similares
-
Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019
por: Shin, Eunyong, et al.
Publicado: (2022) -
Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022) -
Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011) -
Sickle Cell Disease (SCD) Leading to Pulmonary Arterial Hypertension (PAH) and Cholelithiasis (CL)
por: Chacko, Saran, et al.
Publicado: (2023) -
Chronic Obstructive Pulmonary Disease (COPD) is associated with pulmonary artery stiffness - the MESA COPD study
por: Liu, Chia-Ying, et al.
Publicado: (2013)